Studies how circadian clock regulators—particularly REV-ERB nuclear receptors—control glial inflammation, lipid metabolism, oxidative stress, autophagy, and tau pathology in Alzheimer's disease. Uses genetic and pharmacological approaches to identify circadian pathways that may be targeted with chronotherapeutic compounds.